01 / 03
Independent labs
Screen high order volumes arriving from many ordering providers, surface missing diagnoses or documentation, coordinate notices across collection sites, and return signed records to the billing workflow.
QuickIntell ABN Automation for labs
Automate ABN Readiness Before the Lab Test Is Performed
QuickIntell ingests lab orders, extracts clinical and billing context, checks source-linked Medicare and payer rules, and prepares the appropriate Advance Beneficiary Notice of Noncoverage workflow for staff and patient review. The AI supports the decision; it does not make an official payer coverage determination.
$0
implementation fee
$0
customization charges
For a standard ABN Automation module launch. Non-standard migration, third-party fees, multi-system enterprise integrations, and bespoke workflows are scoped separately.
Source-linked decision ledger
Order to notice
- 01
Order received
Order, coverage, service date, ordering provider
- 02
Evidence extracted
Test, codes, diagnoses, documentation, history
- 03
Policy checked
Source, jurisdiction, version, effective date
- 04
Risk classified
Proceed, query, correct, notice candidate, escalate
- 05
Staff action recorded
Review, delivery, patient choice, signature, audit
Every recommendation retains its source, evaluated facts, exception status, and reviewer action.
01 · Built for laboratory operations
Three operating models. One evidence-first control point.
ABN readiness starts before accessioning and billing. QuickIntell adapts intake, review, delivery, and record routing to the way each organization receives orders and serves patients.
02 / 03
Hospital outreach labs
Apply the right billing context to community-provider orders, coordinate decentralized collection workflows, and write the reviewed decision and notice status back to connected LIS and EHR systems.
03 / 03
Pathology groups
Evaluate anatomic and clinical pathology workflows with professional, technical, or global billing context, including reflex and add-on testing that may change the service presented to the patient.
02 · Order intake
Turn fragmented lab orders into reviewable evidence.
The AI normalizes the order and coverage context needed to run a reliable policy check—without requiring a public PHI form or replacing the systems your team already uses.
Intake channels
- 01LIS and EHR interfaces
- 02Practice management and clearinghouse feeds
- 03HL7 v2 and FHIR
- 04REST API
- 05SFTP and controlled batch files
Evidence extracted for review
Payer, plan, line of business, and date of service
Patient coverage and ordering-provider details
Test, panel, CPT, HCPCS, and PLA codes
ICD-10 diagnoses and supporting order documentation
MAC jurisdiction and relevant service location
Frequency and lookback history available to the lab
Prior-authorization status and plan requirements
Good-faith estimated patient cost inputs
NDC detail only when a drug-associated service makes it relevant
Missing facts create an exception—not a guess.
If a diagnosis, document, payer detail, test definition, or history is absent or conflicting, QuickIntell creates a provider-query or staff-review task. The AI never invents a diagnosis or changes a clinical fact to make an order appear covered.
03 · Source-linked policy checks
Know which rule was checked, where it applies, and when it took effect.
QuickIntell evaluates service-date-effective guidance and keeps the policy identity and evaluated facts attached to the result, so reviewers can validate why an order proceeded, stopped, or entered a notice path.
- NCDNational Coverage Determination
- A national Medicare coverage policy evaluated with its effective date, covered indications, limitations, and applicable coding guidance.
- LCDLocal Coverage Determination
- A MAC-specific coverage policy matched to the correct jurisdiction, service date, billing article, and diagnosis requirements.
- NDCNational Drug Code
- A drug package identifier. It is checked only when a drug-associated service makes NDC information relevant; it is not a Medicare coverage determination.
What the agent evaluates
Each result can show the source, policy identifier, jurisdiction, version, effective date, matched facts, and any unresolved exception.
- Original Medicare benefit status and the correct MAC jurisdiction
- NCDs, LCDs, associated billing and coding articles, and Lab NCD diagnosis lists
- Diagnosis-to-test medical-necessity criteria and required order documentation
- Policy versions, service-date effective periods, and superseded guidance
- Frequency and lookback limits for the ordered test or service
- Experimental or investigational status and benefit exclusions
- Panel, reflex, add-on, and repeat-testing context
- Relevant CLIA and performing-laboratory considerations
Separate correction lane
Coding-only NCCI and MUE findings are not ABN triggers.
NCCI procedure-to-procedure edits, Medically Unlikely Edits, unit issues, and modifier conflicts route to a correction queue. An ABN cannot be used to transfer liability for a coding-only denial.
04 · Decision routing
Automation should choose the next review path—not pretend uncertainty is certainty.
The output is an explainable workflow recommendation tied to the order facts and payer context. Authorized staff retain control over the notice, correction, escalation, and billing decision.
01 · Proceed
No notice indicated
The available facts do not create a configured notice candidate, so the order can continue through the lab's normal controls.
02 · Query
Request missing or corrected information
Return an evidence-specific query when the order lacks a diagnosis, documentation, coverage detail, or other fact required for a reliable check.
03 · Correct
Resolve an administrative issue
Route coding, authorization, eligibility, or other correctable operational issues to the appropriate queue rather than treating them as ABN triggers.
04 · Review
Original Medicare ABN candidate
Prepare a source-linked CMS-R-131 candidate for staff review when Original Medicare FFS is expected to deny for an applicable reason such as medical necessity or frequency.
05 · Inform
Voluntary notice candidate
Route a courtesy notice workflow when advance information may help the beneficiary but a mandatory liability-transfer ABN is not the appropriate path.
06 · Plan path
Medicare Advantage workflow
Route an organization-determination and applicable plan-notice workflow. Medicare Advantage does not use CMS-R-131.
07 · Payer path
Commercial notice or consent workflow
Apply the member's payer, plan, contract, network, authorization, and state-specific requirements. There is no universal commercial ABN.
08 · Escalate
Human review required
Hold uncertain, stale, conflicting, low-confidence, or high-risk results for qualified staff instead of forcing an automated decision.
05 · Payer-specific notice logic
One intake layer. Three distinct coverage and notice paths.
Line of business is a first-class decision fact. Original Medicare FFS, Medicare Advantage, and commercial coverage cannot be collapsed into one generic ABN generator.
01
Original Medicare FFS
CMS-R-131 ABN workflow
Evaluate current CMS and MAC guidance, identify a supportable expected-denial reason, and route the current approved form for staff review and advance delivery.
- Current form and instructions
- Specific test or service
- Genuine expected-denial reason
- Good-faith cost estimate
02
Medicare Advantage
Organization determination and plan notices
Use the member's plan process for coverage decisions and applicable notices. CMS-R-131 is not the notice for Medicare Advantage members.
- Plan coverage documents
- Prior-authorization status
- Organization-determination path
- Applicable plan notice requirements
03
Commercial payer
Payer-specific notice and financial consent
Configure the correct workflow by payer, plan, contract, network status, state law, and service context rather than applying a single generic form.
- Medical and reimbursement policy
- Member benefits and exclusions
- Network and authorization rules
- State and federal safeguards
No Surprises Act safeguard
Commercial workflows must not treat an impermissible balance-billing waiver as valid patient consent. In particular, federal protections generally do not allow waiver of surprise billing protections for covered ancillary laboratory services furnished by an out-of-network provider during a visit to an in-network facility. Applicable federal and state requirements must be validated for the specific service.
06 · Notice generation and lifecycle
Generate the notice candidate, preserve the patient's decision.
QuickIntell can prepare and route the workflow, but the form must remain specific, timely, explainable, and controlled by the patient and authorized staff.
- 01
Prepare the permitted fields
Populate the notifier and beneficiary context, the specific test or service, the genuine expected-denial reason, and a good-faith estimated cost on the current approved CMS-R-131 form.
- 02
Require staff validation
A qualified reviewer verifies the coverage path, source, form version, wording, estimate, and timing before the notice can move to the patient.
- 03
Deliver before testing
Issue the notice before the test or service and allow adequate time for an informed decision. A blanket, generic, blank, or retroactive notice is not the intended workflow.
- 04
Capture the patient's choice
Support staff explanation plus electronic or paper delivery. The patient or representative—not the AI or lab—selects an option and signs and dates the form.
- 05
Retain and route the record
Give the beneficiary a paper copy of the signed ABN, route the record to the billing entity, and retain the notice and supporting evidence for five years from discharge or completion of delivery of care, subject to longer applicable requirements.
The patient's decision
Three options. Never preselected.
The AI must not choose an option, prefill a signature, or prefill the signature date. The beneficiary or representative decides after reviewing the notice.
Option 1
Receive the test or service and ask that a claim be submitted to Medicare, with the possibility of payment responsibility if Medicare denies.
Option 2
Receive the test or service, choose not to have a claim submitted to Medicare, and accept the stated payment arrangement.
Option 3
Decline the test or service identified on the notice.
Electronic and paper access
Offer paper issuance as an alternative to electronic delivery and give the beneficiary a paper copy of the signed ABN.
Five years of retention
Retain the signed notice and supporting decision evidence for five years from discharge or completion of delivery of care, subject to any longer applicable requirement.
07 · Auditability and integration
Keep the policy evidence with the notice—not in a separate spreadsheet.
A durable decision record connects what the agent found, what a reviewer approved, what the patient chose, and what moved downstream to billing.
Decision evidence retained
- 01Policy source and policy identifier
- 02MAC jurisdiction, payer, plan, and line of business
- 03Policy version and effective date
- 04Order facts evaluated and missing-data exceptions
- 05Confidence, conflict, and escalation status
- 06Reviewer, review time, and reason-coded overrides
- 07Notice type, approved form version, and generated copy
- 08Delivery method, delivery time, patient choice, and signature
- 09Downstream claim and modifier status when authorized
Additive to the laboratory stack
QuickIntell can sit alongside the LIS, EHR, practice management system, clearinghouse, payer portal, document store, and billing workflow. Reviewed outcomes and signed notice status can return to the system your team already uses to manage the order.
Read
Orders, coverage, documentation, service history, and payer context
Decide
Source-linked recommendation, exception, and required staff review
Write back
Decision status, delivery evidence, signed notice, and downstream disposition
Validate current security evidence during procurement.
Review deployment-specific access, data, audit, and security materials in the QuickIntell Trust Center. This page does not create a new certification or compliance claim.
GA, GX, GY, and GZ evidence and modifier workflows can be supported downstream only after validation by authorized billing staff.
08 · Standard launch
Start with a controlled module launch—not a rip-and-replace project.
The standard launch aligns system data, policy workflows, staff review, and production controls before the module is expanded across additional locations, payers, or test categories.
- 01Source-system mapping
- 02Rule and payer-workflow configuration
- 03Parallel validation against current staff decisions
- 04Role-based staff training
- 05Controlled production launch
Standard module launch
$0
implementation fee
$0
customization charges
For a standard ABN Automation module launch. Non-standard migration, third-party fees, multi-system enterprise integrations, and bespoke workflows are scoped separately.
Subscription and usage pricing are discussed separately. The software itself is not represented as free.
09 · Frequently asked questions
ABN automation questions from lab, pathology, and billing teams.
These answers describe the intended workflow and review boundaries. They do not replace current CMS instructions, payer guidance, legal advice, or organization-specific policy.
01What is an Advance Beneficiary Notice of Noncoverage?
An Advance Beneficiary Notice of Noncoverage, or ABN, is a notice used in Original Medicare FFS when a provider or supplier expects Medicare may not pay for a specific item or service for an applicable reason. It informs the beneficiary before the service and records the beneficiary's choice; it is not a Medicare coverage decision or a guarantee that a claim will be denied.
02When can a lab need an ABN?
A lab may need to consider an ABN when an Original Medicare FFS test is expected to be denied for an applicable reason such as diagnosis-specific medical necessity, an exceeded frequency limit, or experimental or investigational status. The reason must be patient- and service-specific, supported by current guidance, and reviewed before testing. Services that Medicare never covers generally follow a voluntary-notice path rather than a mandatory liability-transfer ABN.
03Does an ABN mean Medicare will deny the test?
No. An ABN communicates the laboratory's expectation based on the facts and guidance available before testing. Medicare makes the coverage and payment determination when it processes a submitted claim. QuickIntell provides decision support and does not guarantee coverage, denial, payment, or transfer of liability.
04What are NCD, LCD, and NDC?
NCD means National Coverage Determination. LCD means Local Coverage Determination and must be matched to the correct Medicare Administrative Contractor jurisdiction and service date. NDC means National Drug Code, a drug package identifier checked only when a drug-associated service makes it relevant; NDC is not a coverage determination.
05Can QuickIntell invent or change a diagnosis?
No. QuickIntell extracts order and documentation facts but must not create, infer as fact, or alter a diagnosis to satisfy a coverage rule. Missing, ambiguous, or conflicting clinical information is routed to an authorized provider-query or staff-review workflow.
06Can an NCCI or MUE coding edit justify an ABN?
Not by itself. Coding-only NCCI procedure-to-procedure or Medically Unlikely Edit denials do not transfer liability through an ABN. QuickIntell keeps those findings in a separate correction queue so coding, units, or modifier issues can be resolved without being misrepresented as medical-necessity ABN triggers.
07Does CMS-R-131 apply to Medicare Advantage?
No. CMS-R-131 is the ABN used for Original Medicare FFS. Medicare Advantage members follow the plan's organization-determination process and applicable plan or CMS managed-care notices. The workflow must identify the member's line of business before selecting a notice path.
08Is there an ABN form for commercial insurance?
There is no universal commercial ABN. Commercial workflows must follow the applicable payer and plan policies, member benefits, provider contract, prior-authorization and network rules, state law, and federal protections. A payer-specific noncoverage notice or financial-consent document must not be presented as CMS-R-131.
09How are panels, reflex tests, frequency limits, and estimates handled?
QuickIntell evaluates the ordered and expected billable services, including panel components, reflex or add-on logic, available prior-service history, and the policy's lookback period. The notice candidate identifies the specific test or service at risk and uses configured charge and coverage inputs to prepare a good-faith estimate for staff review.
10Can the beneficiary sign electronically?
Electronic issuance and digitally captured signatures can be supported when the beneficiary can review the full notice and make an informed choice. The workflow must offer paper issuance as an alternative and give the beneficiary a paper copy of the signed ABN. The electronic record must preserve the same required content, choice, signature, date, delivery, and retention evidence as the paper workflow.
11Can AI select the beneficiary's option?
No. The AI and laboratory must never preselect Option 1, Option 2, or Option 3, and must not prefill the beneficiary or representative signature or date. The beneficiary or representative makes the choice after receiving an explanation and adequate time to decide.
12How long are signed notices retained?
Signed ABNs and related delivery and decision evidence are generally retained for five years from discharge or completion of delivery of care, subject to any longer federal, state, contractual, litigation-hold, or organizational requirement that applies to the laboratory.
13Can an ABN be delivered during an emergency or under duress?
No. A notice should not be obtained during a medical emergency, under great duress, or through coercion because the beneficiary must be able to make a reasoned, informed choice. In a hospital setting, the workflow must not delay an EMTALA-required medical screening examination or stabilizing treatment. These cases stop for qualified staff instead of forcing notice delivery.
14What happens if the beneficiary refuses to choose or sign?
The workflow must not select or sign for the beneficiary. Staff should follow the current CMS instructions, including annotating the original ABN to document the refusal, providing the beneficiary a copy of the annotated notice, and retaining the original in the record. Whether to furnish the test requires a staff decision that accounts for patient health and safety, applicable law, and the consequences of an unsigned notice; the software does not assume that liability transferred.
15How are language, accessibility, and comprehension needs handled?
A valid workflow must support a capable recipient's understanding, not merely present a form. Staff can route the current available CMS form, oral explanation, interpreter or translator support, assistive technology, and an authorized-representative path as appropriate, then document how the notice was delivered and explained. QuickIntell flags the required workflow; authorized staff remain responsible for effective communication and current accessibility obligations.
16Can one ABN cover standing orders or repetitive lab testing?
A single ABN may describe an extended or repetitive course of expected noncovered testing when it identifies all affected items or services and, when applicable, the duration. A new ABN is needed when the described care, the beneficiary's health status, the relevant coverage guidance, or the services change. A notice cannot be backdated or used to shift liability for testing performed before valid delivery.
17Does ABN Automation guarantee coverage or payment?
No. QuickIntell is AI-assisted workflow and decision-support software. It does not make an official payer determination and does not guarantee that a notice is valid, that liability will transfer, or that a payer will cover, deny, or pay a test. Authorized laboratory staff remain responsible for the final workflow and billing decision.
18What is included in the standard $0 launch?
The standard ABN Automation module launch includes source-system mapping within the standard connector scope, rule and workflow configuration, parallel validation, staff training, and a controlled production launch with a $0 implementation fee and $0 customization charges. Non-standard migration, third-party fees, multi-system enterprise integrations, and bespoke workflows are scoped separately.
10 · Official policy sources
Review the source behind the workflow.
Policy content on this page was reviewed August 27, 2026. CMS, MAC, plan, payer, and legal requirements can change; production rules should always use the service-date-effective source.
CMS FFS ABN
Current Original Medicare FFS ABN forms and notices.CMS-R-131 form instructions
Official instructions for completing and delivering the ABN.Medicare Claims Processing Manual, Chapter 30
Financial-liability notice rules, delivery, and retention guidance.CMS coverage determination process
NCD and LCD coverage-policy context.FDA National Drug Code background
The FDA definition and purpose of NDC identifiers.CMS NCCI FAQ
Official guidance separating coding edits from ABN liability transfer.CMS Medicare Advantage notices
Managed-care organization determinations and notice resources.CMS No Surprises Act provider FAQ
Federal patient-protection considerations for provider workflows.Continue exploring QuickIntell
Important notice
QuickIntell provides AI-assisted workflow and decision support. It is not legal advice, an official payer determination, or a guarantee of coverage, payment, notice validity, or liability transfer. The laboratory or provider remains responsible for policy applicability, notice delivery, coding, patient communication, and billing.
QuickIntell ABN Automation
Put medical-necessity evidence in the workflow before the test.
See how QuickIntell can connect order intake, source-linked policy checks, staff review, payer-specific notices, patient choice, and audit retention for your laboratory operation.